Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 18 to 75

Non-invasive therapies to improve arm and hand function in spinal cord injury

Official title: Comparative Evaluation of Non-Invasive Neuromodulation Therapies to Restore Upper Extremity Function in Chronic Cervical Spinal Cord Injury

Run by University of Alberta · NCT06903416 · Data updated 2026-11-12

This study is testing two new therapies to see if they can help people with spinal cord injuries improve their arm and hand function.

More Spinal Cord Injury Cervical trials

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment10 (estimated)
SponsorUniversity of Alberta
Academic / other
Locations1 site (Edmonton, Alberta)
StatusRecruiting
StartedMay 7, 2025
Main results expectedMarch 30, 2030
Study endsMarch 31, 2030
Registry record updatedMay 29, 2026
Trial IDNCT06903416 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with cervical spinal cord injuries who are more than nine months post-injury and have stable doses of anti-spasmodics.

Probably not a fit

Patients with injuries to the nervous system other than the spinal cord or those who are pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates two non-invasive therapies aimed at restoring arm and hand function in individuals with chronic cervical spinal cord injury. Participants will undergo a crossover design, receiving transcutaneous spinal cord stimulation and paired corticospinal-motoneuronal stimulation, each combined with rehabilitation, for two months with a one-month washout period in between. The study will assess safety, effectiveness, and patient-reported outcomes related to daily living and quality of life, alongside neurophysiological changes. The goal is to tailor treatments to individual needs, enhancing personalized care and outcomes.

Why it matters

Potential benefit: If successful, this study could significantly improve upper extremity function and quality of life for patients with spinal cord injuries.

How similar studies have gone: Other studies have shown promise with similar non-invasive neuromodulation approaches, indicating potential for success in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Cervical (C2-C8) level SCI
* \> 9 months post-injury
* Traumatic SCI
* AIS A-D
* Stable dose of anti-spasmodics

Exclusion Criteria:

* individuals with injury to the nervous system other than to the spinal cord
* pregnant

Where it's running

  • Glenrose Rehabilitation Hospital
    Edmonton, Alberta, Canada
    Recruiting

Study contacts

  • Principal investigator: Jessica M D'Amico, PhD — University of Alberta
  • Study coordinator: Jessica M D'Amico, PhD
  • Email: damico1@ualberta.ca
  • Phone: 7802039478

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.